The Zhitong Finance App learned that on September 2, JD Health (06618.HK) and Licang Life Technology reached a strategic cooperation. The two sides will focus on innovative directions of precise immunotherapy for tumors such as personalized mRNA tumor vaccines, focusing on cooperation in patient services, medical collaboration, clinical research subject recruitment, and high-end health management services. As the first stop for the launch of new specialty drugs, the two sides will provide launch support for new cancer vaccine products, and jointly promote a more efficient and standardized connection between cutting-edge technology, medical services and patient needs.

The Zhitong Finance App learned that on September 2, JD Health (06618.HK) and Licang Life Technology reached a strategic cooperation. The two sides will focus on innovative directions of precise immunotherapy for tumors such as personalized mRNA tumor vaccines, focusing on cooperation in patient services, medical collaboration, clinical research subject recruitment, and high-end health management services. As the first stop for the launch of new specialty drugs, the two sides will provide launch support for new cancer vaccine products, and jointly promote a more efficient and standardized connection between cutting-edge technology, medical services and patient needs.